Showing posts with label European Commission. Show all posts
Showing posts with label European Commission. Show all posts

Monday, 16 July 2007

EU Carbon Emission Permits Fall to Two-Month Low as Allocations Are Raised

(Bloomberg) -- European Union carbon dioxide permits
for 2008 fell to a two-month low after the European Commission
raised the allocation of emission allowances for Ireland and Latvia
in the five years through 2012, increasing supply.

The July 13 decision increases the total number of permits
allocated by 1.08 million metric tons of carbon dioxide a year.
Permits for December 2008 fell 89 cents, or 4.5 percent, to 19
euros ($26.19) a ton at 3:45 p.m. local time on the European
Climate Exchange in Amsterdam.


Read more at Bloomberg Energy News

EU Carbon Emission Permits Fall Near Two-Month Low As Allocations Raised

(Bloomberg) -- European Union carbon dioxide permits
for 2008 fell near a two-month low after the European Commission
raised the allocation of emission allowances for Ireland and
Latvia in the five years through 2012, increasing supply.

The July 13 increase boosts the total number of permits
allocated by 1.08 million tons of carbon dioxide a year. Permits
for December 2008 fell 19 cents, or 1 percent, to 19.70 euros
($27.12) a ton at 10:19 a.m. local time on the European Climate
Exchange in Amsterdam.


Read more at Bloomberg Energy News

European Emission Permits Fall After Allocations Raised, Imports Curbed

(Bloomberg) -- European Union carbon dioxide permits
for 2008 fell near a two-month low after the European Commission
raised the allocation of emission permits for Ireland and Latvia in
the five years through 2012, increasing supply.

The commission, the regulatory arm of the EU, has ruled on the
requests for allocations of 22 out of the EU's 27 member nations.
It forced an average cut of 9.4 percent for a total of 1.898
billion metric tons a year, according to a statement on July 13.


Read more at Bloomberg Energy News

Thursday, 28 June 2007

Inverness Medical gets FDA nod for malaria test device

(Reuters) - The drug maker said Januvia is the first and only medication in the class of drugs called dipeptidyl peptidase-4 inhibitors, which enhance the body's ability to lower blood sugar when it is elevated, to be adopted by the European Commission.






Read more at Reuters.com Government Filings News

Monday, 25 June 2007

Europe approves once-daily Cialis for impotence

(Reuters) - The drug's maker, Eli Lilly and Co. , said on Monday that the green light from the European Commission meant Cialis was the first erectile dysfunction medicine cleared for continuous use.



Until now, drugs such as Cialis and Pfizer Inc.'s rival product, Viagra, have been taken as needed.


Read more at Reuters.com Government Filings News